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Effectiveness and safety of dialysis vascular access procedures
performed by interventional nephrologists.
Background. The purpose of this report was to analyze the
results obtained from a group of interventional nephrologists
working in multiple centers performing basic procedures that
are used routinely in the management of vascular access prob-
lems, with an effort toward establishing standards for evaluating
success, complication rates, and acceptable times for procedure
duration and fluoroscopy.
Methods. Data on six basic procedures were analyzed—
angioplasty of arteriovenous fistulas (AVF-PTA), angioplasty
of synthetic grafts (graft-PTA), thrombectomy of arteriove-
nous fistulas (AVF declot), thrombectomy of synthetic grafts
(graft declot), placement of tunneled dialysis catheters (TDC
placement), and tunneled dialysis catheter exchange (TDC ex-
change). These data were examined both as a group and by
individual physician operator.
Results. A total of 14,067 cases were performed under the
six categories of procedure that were the subject of this report;
13,503 cases (96.18%) were successful. The overall complica-
tion rate for the combined group of procedures was 3.54%,
with 3.26% falling within the minor category and 0.28% within
the major. The number of cases performed in each individ-
ual category with success rates for each were as follows: TDC
placement—1765 cases, 98.24% successful; TDC exchange—
2262 cases, 98.36% successful, AVF-PTA—1561 cases, 96.58%
successful; graft-PTA—3560 cases, 98.06% successful; AVF
declot—228 cases, 78.10% successful; graft declot—4671 cases,
93.08% successful.
Conclusion. This study demonstrates that appropriately
trained interventional nephrologists can perform these basic
procedures in both a safe and effective manner.
In the United States, hemodialysis vascular access
represents an enormous problem. Its management is a
procedure-intensive endeavor. Increasingly, these proce-
dures are being performed by interventional nephrolo-
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gists who have shown that, with appropriate training, they
can perform a major portion of the procedures that are
necessary for access management.
Simply stated, an interventional nephrologist is a
nephrologist that performs interventional procedures es-
sential to the management of patients with renal disease.
Classically, the nephrologist has performed kidney biop-
sies and inserted temporary dialysis catheters. In recent
years, a few in this specialty have started inserting peri-
toneal dialysis catheters. The newest development has
been in the area of interventional procedures necessary
for dialysis vascular access maintenance. These proce-
dures include tunneled catheter placement and exchange,
along with angioplasty and thrombolysis procedures on
synthetic grafts and native fistulas. This type of activity,
management of the hemodialysis vascular access, repre-
sents the primary focus of the interventional nephrolo-
gist’s activity.
Interventional nephrology is becoming an active sub-
specialty of nephrology. Although the trend has begun to
change with the recent development of academic train-
ing programs, the subspecialty originated, developed, and
continues to grow primarily within the private practice
setting. In the absence of academic involvement, there
has not been a comprehensive publication of clinical
results.
The purpose of this study was to present a large body
of data derived from a diverse group of interventional
nephrologists performing basic procedures that are used
routinely in the management of hemodialysis patients
with vascular access problems. Although diverse, these
physician operators are performing these procedures us-
ing standardized techniques.
METHODS
Design of study
The data utilized for this study were derived from
11 freestanding outpatient interventional facilities lo-
cated in different regions of the United States [Atlanta,
GA; Baltimore, MD; Birmingham, AL; Cincinnati, OH;
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Detroit, MI (two); Houston, TX; Riverside, CA; San
Diego, CA; Tyler, TX; and Wichita, KS]. A total of 29
interventional nephrologists were involved in perform-
ing the procedures from which the data were gathered,
although not all operators participated for the full period
of the study. All of these interventionalists, except for
four, were trained in the RMS Lifeline training program,
which is accredited by the American Society of Diagnos-
tic and Interventional Nephrology. In some instances, the
period of an individual physician operator’s participation
in this study included their training period. All except one
are associated with private practice nephrology groups.
The patient populations served by these interventional
facilities range from 475 to 2200.
The data used for this study were collected prospec-
tively over a period of one year (the calendar year 2003)
as part of a fully electronic centralized medical record
system. Monthly verification of the electronic record was
performed against each individual procedure room log
for quality assurance purposes. Individual patient data
were then randomly selected for verification against the
medical record, and the physician procedure note by us-
ing a random number generator. Patient follow-up data
were collected by review of patient records at individual
dialysis facilities.
Data on six basic procedures were analyzed for
this study—angioplasty of arteriovenous fistulas [AVF-
percutaneous transluminal angioplasty (PTA), angio-
plasty of synthetic grafts (graft-PTA), thrombectomy of
arteriovenous fistulas (AVF declot), thrombectomy of
synthetic grafts (graft declot), placement of tunneled dial-
ysis catheters (TDC placement), and tunneled dialysis
catheter exchange (TDC exchange). The data collected
consisted of the total number of each procedure per-
formed, the success rate, the aborted procedure rate, the
procedure failure rate, the complication rate along with
the types of complications observed, the procedure time,
and the fluoroscopy time. These data were examined both
as a group and by individual physician operator.
Description of procedures performed
Tunneled catheter (TDC) placement. All TDCs were
placed using both ultrasound and fluoroscopic guidance.
Preferred sites for placement in their order of prefer-
ence were right internal jugular vein, left internal jugular
vein, and femoral vein. The TDC placement procedure
was classified as successful if the catheter could achieve
blood flow sufficient to perform a single hemodialysis
treatment without significantly changing the dialysis pre-
scription. Sufficient blood flow was defined as 300 mL/min
or greater [1]. Blood flow was verified with the dialysis
facility on all catheters.
Tunneled catheter (TDC) exchange. The indications
for TDC exchange were catheter dysfunction (thrombo-
sis) and catheter-related infection. Catheters were ex-
changed over a guidewire with fluoroscopic guidance.
Where indicated, a new tunnel and exit site was cre-
ated, but in most instances, the TDC was exchanged uti-
lizing the preexisting site. Angiography was performed
routinely at the time of catheter exchange to detect the
presence of a fibrin sheath. If a sheath was detected it was
ablated prior to the placement of the new catheter. The
same criteria were used to judge success as for primary
catheter placement [1].
Angioplasty (PTA). Both the AVF-PTA and the graft-
PTA were performed using a similar technique. Only le-
sions found to be 50% stenotic or greater were treated.
The access was cannulated at a point determined by the
expected location of the anticipated stenotic lesion based
upon physical examination of the access. After cannula-
tion, an initial angiogram was performed to identify the
pathology. A guidewire was then introduced. The size
of the angioplasty balloon was selected so as to provide
20% to 30% overdilatation of the vein. Dilatation was
generally affected using pressure generated by hand with
a 10 mL syringe for routine situations and a 3 mL sy-
ringe for more resistant lesions. The degree of stenosis
and the degree of residual were both determined by esti-
mation by the operator using the adjacent normal vessel
or graft, and not by actual measurement. The percent-
age stenosis of the original lesion and the percentage
of the residual were both recorded. Inflow evaluation
was performed where medically indicated, along with an-
gioplasty of any significant lesions identified at the arte-
rial anastomosis or within the adjacent artery. A residual
stenosis of 30% or less as prescribed by National Kidney
Foundation-Kidney/Dialysis Outcome Quality Initiative
(NKF-K/DOQI) Guideline 19 [2] was used as the defini-
tion of success for all angioplasty procedures.
Thrombectomy (declot). Endovascular thrombec-
tomy was performed by mechanical means. Although the
technique varied slightly from one facility to another, the
technique used in all instances could best be categorized
as thromboaspiration. This is a combined procedure in-
volving angiography to evaluate the anatomy and local-
ize stenotic lesions, balloon-assisted thrombectomy with
thrombus aspiration through a sheath, and angioplasty to
treat any associated venous stenosis. Mechanical devices
and thrombolytic enzymes were not routinely used. In
the case of fistulas, treatment varied somewhat depending
on thrombus size and included balloon-assisted mechan-
ical thrombectomy, and pharmacomechanical thrombol-
ysis using tPA (CathfloTM Activase, Genentech, South
San Francisco, CA, USA). Inflow evaluation was rou-
tinely performed in all thrombectomy cases, along with
angioplasty of any significant lesions identified at the ar-
terial anastomosis or the adjacent artery. The percent-
age stenosis of all associated lesions and the percentage
of any residual left following angioplasty were recorded.
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The thrombectomy procedure was considered successful
if unobstructed flow through the access could be suffi-
ciently established and was persistent enough to allow
for one subsequent normal dialysis [3].
An arteriogram was done routinely during the course
of the thrombectomy procedure to evaluate the arte-
rial anastomosis, juxta-anastomotic access, and the adja-
cent artery. In general, however, an arterial embolus was
looked for only in cases with ischemic symptoms suggest-
ing its presence.
Medical management during procedure
In most cases, patients were sedated with either mi-
dazolam (Versed) or a combination of midazolam and
fentanyl (Sublimaze) during these procedures. Blood
pressure, pulse, EKG, and oxygen saturation were mon-
itored continuously during the conduct of all procedures
by a trained nurse, who was also responsible for recording
all complications.
Definitions
Procedure outcomes. The outcome for each procedure
performed was recorded as successful, failed, or aborted.
The definitions of success for each of the six procedures
were as defined above. A failed procedure was one that
was completed but did not meet the stated criteria for suc-
cess. An aborted procedure was one that was attempted
but could not be completed and was abandoned. In ac-
tuality, all procedures are either successful or unsuccess-
ful, and this determination should be based upon intent
to treat; however, there is a subtle difference between
aborted and failed that is of value in the evaluation of an
operator’s performance for quality improvement (CQI)
purposes. For this reason, these definitions were used
here. Both terms, failed and aborted, should be regarded
as unsuccessful procedures.
Complications. The complications observed in this
study were classified according to the reporting stan-
dards of the Society for Interventional Radiology [4].
According to this standard, all complications, including
pulmonary and cardiac events that occur within 30 days
following the procedure, are considered procedure re-
lated. Minor complications are those that require either
no therapy or only nominal therapy, and which are re-
solved without any adverse consequence. Major compli-
cations are defined as those that require an increase in
the level of care, or result in hospitalization, permanent
adverse sequelae, or death.
In addition, each type of complication was individ-
ually tabulated for each procedure. In doing this, the
classification of hematomas previously described [5] was
used in tabulating that type of complication in PTA and
thrombectomy cases. Each of these represents a degree
of vein rupture heralded by the extravasation of con-
trast, blood, or both, resulting in the appearance of a
hematoma. In summary, this classification is as follows:
grade 1 hematoma—stable and does not affect flow, grade
2 hematoma—stable and either slows or stops flow, grade
3 hematoma—represents a complete rupture of the ves-
sel, resulting in a hematoma that is not stable but contin-
ues to expand. This generally results in a loss of the access.
Grades 1 and 2 are considered minor complications, and
a grade 3 hematoma is defined as a major complication.
These designations are independent of determinations of
success of the procedure, although they can obviously af-
fect it. For example, if a grade 2 hematoma stops flow,
but can be successfully treated to restore flow, the suc-
cess of the procedure will be unchanged. However, if it
cannot be treated successfully, it will result in a failure of
the associated procedure.
Delayed bleeding was defined as a bleeding episode
that required medical managemen after initial hemosta-
sis had been obtained. A reaction to medication was,
in most instances, an adverse reaction to radiocontrast.
If the oxygen saturation dropped to less than 90% at
any point during the procedure, it was recorded as a
complication.
Timed components of procedures. The procedure time
was defined as the time that lapsed between the initial ad-
ministration of local anesthesia and either the completion
of any suturing that was required in the case of catheter in-
sertion procedures or the completion of any process used
to obtain hemostasis in the case of peripheral access re-
lated procedures. It did not include site preparation time
or hemostasis time, the latter being the time required to
actually obtain hemostasis. With peripheral access (graft
and AVF) related procedures, hemostasis was obtained
either by the placement of a suture at the cannulation
sites or the application of an adhesive, collagen-coated,
compression dressing (Tip-Stop, Cobe, Gambro Hospal
Co., Lakewood, CA, USA) along with digital pressure.
The end of the timing of procedure time was signaled
by the completion of the suture or the application of the
dressing.
The cumulative time that fluoroscopy was activated
during the procedure was totaled and recorded by the
machine itself. This recorded time was transferred into
the medical record at the end of each procedure and des-
ignated as the fluoroscopy time for that procedure.
Once the mean procedure and fluoroscopy times were
determined for individual operators for each category of
procedure, a median for these mean times was identified
to serve as an index of efficiency for individual operators
within the group.
RESULTS
Combined series
A total of 14,067 cases were performed under the six
categories of procedure that were the subject of this
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Fig. 1. Number of cases in each category. TDC place, tunneled dialy-
sis catheter placement; TDC exchange, tunneled dialysis catheter ex-
change; AVF-PTA, arteriovenous fistula angioplasty; Graft-PTA, graft
angioplasty; AVF declot, arteriovenous fistula thrombectomy; Graft de-
clot, graft thrombectomy; overall, combined group.
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Fig. 2. Success rate for each category. TDC place, tunneled dialy-
sis catheter placement; TDC exchange, tunneled dialysis catheter ex-
change; AVF-PTA, arteriovenous fistula angioplasty; Graft-PTA, graft
angioplasty; AVF declot, arteriovenous fistula thrombectomy; Graft de-
clot, graft thrombectomy; overall, combined group.
report (Fig. 1). Using the adopted definitions, 13,503 cases
(96.18%) were successful (Fig. 2). The procedure failed
in 414 cases, or 2.94%, and was aborted in 150 cases, or
1.06% (Table 1). The overall complication rate for the
combined group of procedures was 3.54% (Fig. 3), with
3.26% falling within the minor category and 0.28% within
the major (Table 1). The mean procedure time for the
combined series was 39.5 ± 25.6 minutes. The fluoroscopy
time mean was 5.9 ± 5.7 minutes (Table 2).
Placement of tunneled dialysis catheters
(TDC placement)
This procedure was performed in 1765 (12.54%) of the
cases in this series (Table 1). This was successful accord-
ing to the stated definition in 1734 (98.24%) of the cases.
The procedure was classified as failed in 19 (1.08%) of
the patients, and was aborted in 12 (0.68%). The num-
ber of catheters placed by an individual operator ranged
from 3 to 183. The median number of cases performed
Table 1. Summary of procedures performed
Complication
Procedurea Number Success Failed Aborted Minor Major
TDC 1765 98.24% 1.08% 0.68% 1.36% 0.06%
placement
TDC 2262 98.36% 1.11% 0.53% 1.37% 0.04%
exchange
AVF- PTA 1561 96.58% 2.63% 0.83% 4.29% 0.19%
Graft—PTA 3560 98.06% 1.52% 0.42% 1.04% 0.11%
AVF declot 228 78.10% 16.67% 5.26% 6.07% 0.44%
Graft declot 4671 93.08% 5.07% 1.84% 5.99% 0.62%
Combined 14,067 96.18% 2.94% 1.06% 3.26% 0.28%
aTDC placement, tunneled dialysis catheter placement; TDC exchange,
tunneled dialysis catheter exchange; AVF-PTA, arteriovenous fistula angioplasty;
graft-PTA, graft angioplasty; AVF declot, arteriovenous fistula thrombectomy;
graft declot, graft thrombectomy; PTA, percutaneous transluminal angiography.
0%
1%
2%
3%
4%
5%
6%
7%
Ov
er
all
TD
C p
lac
e
TD
C
ex
ch
an
ge
AV
F-P
TA
Gr
aft
-PT
A
AV
F d
ec
lot
Gr
aft
 de
clo
t
Fig. 3. Complication rate for each category. Columns in rear, minor
complications; columns in front, major complications. TDC place, tun-
neled dialysis catheter placement; TDC exchange, tunneled dialysis
catheter exchange; AVF-PTA, arteriovenous fistula angioplasty; Graft-
PTA, graft angioplasty; AVF declot, arteriovenous fistula thrombec-
tomy; Graft declot, graft thrombectomy; overall, combined group.
in this category was 60. The individual operator success
rate ranged from 71.4% (14 cases performed) to 100%
(3 to 159 cases performed). The operator with the great-
est number of cases (183) had a success rate of 99.4%.
There were 25 (1.42%) adverse events; 24 (1.36%) of
these met the definition of a minor complication, and 1
(0.06%) fell within the major category. Of the minor com-
plications, 23 (1.30%) were delayed bleeding requiring
medical management, and one was a reaction to medica-
tion. The single major complication was a pneumothorax.
This was managed by the interventional nephrologist.
The mean procedure time (Table 2) for all TDC place-
ments was 33.2 ± 18.6 minutes. The median time was
28 minutes, with a range of 10 to 100 minutes. The me-
dian for individual operator mean procedure times was
34.9 ± 19 minutes (88 cases performed), with a range of
22.9 ± 12.4 (169 cases performed) to 67 ± 16.5 minutes
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Table 2. Timed components of procedures
Procedure time Fluoroscopy time
Procedurea Mean Median Range Mean Median Range
TDC placement 33.2 ± 18.6 28 10–100 2.8 ± 3.0 1.9 0.1–27.9
TDC exchange 31.6 ± 20.1 26 3–90 2.9 ± 3.3 2.0 0.1–35.2
AVF-PTA 38.8 ± 23.9 33 3–185 6 ± 4.8 4.6 0.3–34.8
Graft-PTA 24.4 ± 15.5 20 3–179 4 ± 3 3.2 0.2–31.8
AVF declot 88.8 ± 41.8 84 15–120 14.6 ± 10 12.2 0.4–56.4
Graft declot 51.8 ± 27.6 45 12–220 8.8 ± 6.4 6.9 0.2–48.5
Combined 39.5 ± 25.6 33 3–220 5.9 ± 5.7 4.2 0.1–56.4
aTDC placement, tunneled dialysis catheter placement; TDC exchange, tunneled dialysis catheter exchange; AVF-PTA, arteriovenous fistula angioplasty; graft-PTA,
graft angioplasty; AVF declot, arteriovenous fistula thrombectomy; graft declot, graft thrombectomy; PTA, percutaneous transluminal angiography.
(4 cases performed). The mean fluoroscopy time was
2.8 ± 3 minutes, with a median of 1.9 minutes and a range
of 0.1 to 27.9 minutes. The median for individual operator
mean fluoroscopy times was 3.1 ± 2.6 minutes (88 cases
performed), with a range of 0.9±1.2 (98 cases performed)
to 11 ± 9.9 minutes (4 cases performed).
Tunneled dialysis catheter exchange (TDC exchange)
There were 2262 (16.08%) cases of TDC exchange in
this series (Table 1). The procedure was successful in
2225 cases (98.36%). Only 25 (1.11%) of the cases failed,
and 12 (0.53%) were aborted. The number of catheter
exchanges performed by an individual operator ranged
from 7 to 169. The median number of cases performed in
this category was 89. The individual operator success rate
ranged from 85.7% (5 cases performed) to 100% (11 to
169 cases performed). The operator who had the greatest
number of cases (169) had a success rate of 100%.
Complications were recorded in 32 (1.41%) instances,
all of which were of the minor variety. Delayed bleeding
was the problem in 29 (1.28%) of the cases, an oxygen
saturation less than 90% was observed during the proce-
dure in two cases, and a reaction to medication was see
in one instance.
The mean procedure time (Table 2) for all TDC ex-
changes was 31.6 ± 20.1 minutes. The median time was
26 minutes, with a range of 3 to 90 minutes. The median
for individual operator mean procedure times was 28.5
± 19.1 minutes (110 cases performed), with a range of
13.4 ± 6.6 (50 cases performed) to 81.2 ± 32.5 minutes
(14 cases performed). The mean fluoroscopy time was 2.9
± 3.3 minutes, with a median of 2.0 minutes and a range
of 0.1 to 35.2 minutes. The median for individual oper-
ator mean fluoroscopy times was 2.5 ± 2.1 minutes (42
cases performed), with a range of 0.9 ± 0.7 (130 cases
performed) to 6.9 ± 6.1 minutes (7 cases performed).
Angioplasty of arteriovenous fistulas (AVF-PTA)
This procedure was performed 1561 times in this se-
ries (Table 1). This represented 11.1% of the total. The
results obtained were classified as successful in 96.58%
of the cases, or in 1527 patients. The procedure failed in
2.63% or 41 cases, and was aborted in 0.83%, or 13 cases.
The number of AVF-PTAs performed by an individual
operator ranged from 1 to 121. The median number of
cases performed in this category was 55. The individual
operator success rate ranged from 0% (1 case performed)
to 100% (6 to 97 cases performed). The operator who had
the greatest number of cases (121) had a success rate of
94.2%.
The percentage of stenosis present in association with
fistulas was judged to be 74.1% ± 14.1%. Following an-
gioplasty it had been reduced to 12.9% ± 6.6%. A total
of 70 complications were encountered, representing an
incidence of 4.48%. Of these, 4.29% were minor com-
plications. A grade 1 hematoma was seen in 53 (3.35%),
a grade 2 hematoma in 6 (0.4%), an episode of oxygen
saturation less than 90% in 2, delayed bleeding in 3, and
a reaction to medication in 3 cases. Major complications
were seen in 3 patients, or 0.19% of the total, all of which
were grade 3 hematomas.
The mean procedure time (Table 2) for all AVF-PTAs
was 38.8 ± 23.9 minutes. The median time was 33 min-
utes, with a range of 3 to 185 minutes. The median for
individual operator mean procedure times was 34.2 ±
22.3 minutes (92 cases performed), with a range of 17 ±
10.6 (62 cases performed) to 59.2 ± 24.4 minutes (59
cases performed). The mean fluoroscopy time was 6 ±
4.8 minutes, with a median of 4.6 minutes and a range
of 0.3 to 34.8 minutes. The median for individual oper-
ator mean fluoroscopy times was 5.5 ± 2.9 minutes (42
cases performed), with a range of 2.2 ± 0.9 (121 cases
performed) to 10.5 ± 7.1 minutes (103 cases performed).
Angioplasty of synthetic grafts (graft-PTA)
A graft-PTA was performed in 3560 cases, or 25.31%
of the total (Table 1). Success was obtained with this pro-
cedure in 98.06%, or 3491 patients. Only 54 (1.52%) cases
failed, and 15 (0.42%) were aborted. The number of graft-
PTAs performed by an individual operator ranged from
25 to 278. The median number of cases performed in this
category was 110. The individual operator success rate
ranged from 91.8% (49 cases performed) to 100% (25 to
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59 cases performed). The operator who had the greatest
number of cases (278) had a success rate of 98.6%.
The percentage of stenosis present in association with
grafts was 73.7% ± 14.7%. This was reduced to a resid-
ual of 17.2% ± 9.1%. There were 41 complications in
this group, or 1.15%, 37 (1.04%) of which were minor,
and 4 (0.11%) that were classified as major complica-
tions. Of the minor complications, 27 (0.76%) were grade
1 hematomas, and 4 (0.11%) were grade 2. Oxygen sat-
uration less than 90% occurred during the procedure in
3 cases, and an additional 3 cases experienced a reaction
to medication. The major complications consisted of 2
patients who experienced a grade 3 hematoma and 2 pa-
tients who died within the 30-day period following the
procedure.
The mean procedure time (Table 2) for all graft-PTAs
was 24.4 ± 15.5 minutes. The median time was 20 min-
utes, with a range of 3 to 179 minutes. The median for
individual operator mean procedure times was 23.6 ± 8.6
minutes (138 cases performed), with a range of 16 ± 6.3
(140 cases performed) to 38 ± 23.5 minutes (49 cases per-
formed). The mean fluoroscopy time was 4 ± 3 minutes,
with a median of 3.2 minutes and a range of 0.2 to 31.8
minutes. The median for individual operator mean fluo-
roscopy times was 4 ± 1.7 minutes (138 cases performed),
with a range of 2.0 ± 1.8 (60 cases performed) to 6.5 ±
4.5 minutes (27 cases performed).
Thrombectomy of arteriovenous fistulas (AVF declot)
An AVF declot was performed in 228 cases in this se-
ries (Table 1). This represented 1.62% of the total proce-
dures. Of these cases, 178 (78.10%) were successful and
38 (16.67%) failed. Twelve cases (5.26%) were aborted.
The number of AVF declots performed by an individ-
ual operator ranged from 1 to 30. The median number
of cases performed in this category was 8. The individual
operator success rate ranged from 0% (1 case performed)
to 100% (1 to 9 cases performed). The operator who had
the greatest number of cases (30 cases) had a success rate
of 83.3%.
The complication rate was 7.89%, with complications
being recorded in 18 cases. These were classified as mi-
nor in 17 cases (7.45%), and major in only 1 (0.44%)
patient. The minor complications consisted of a grade 1
hematoma in 13 cases (5.7%), and a grade 2 hematoma in
2 cases (0.88%). Oxygen saturation below 90% occurred
once, and delayed bleeding was reported in one case. The
single major complication was a grade 3 hematoma.
The mean procedure time (Table 2) for all AVF declots
was 88.8 ± 41.8 minutes. The median time was 84 minutes,
with a range of 15 to 120 minutes. Because of the small
numbers of cases performed by some operators, times
for individual operators were analyzed only for those
with eight or more cases. For these operators, the me-
dian for individual operator mean procedure times was
85.3 ± 35.9 minutes, with a range of 59.8 ± 29.4 to 117.8
± 32.2 minutes. The mean fluoroscopy time was 14.6 ±
10 minutes, with a median of 12.2 minutes and a range of
0.4 to 56.4 minutes. For individual operators with eight
or more cases, the median for individual operator mean
fluoroscopy times was 13.6 ± 10.3 minutes, with a range
of 7.1 ± 3.4 to 24.8 ± 10.6 minutes.
Thrombectomy of synthetic grafts (graft declot)
A graft declot was performed in 33.21% of the cases
in this series, or 4671 times (Table 1). A 93.08% success
rate was observed, which represented 4348 cases. Fail-
ure was reported in 237 cases (5.07%), and the proce-
dure was aborted in 86 instances (1.84%). The number of
graft declots performed by an individual operator ranged
from 28 to 325. The median number of cases performed
in this category was 148. The individual operator success
rate ranged from 78.4% (133 cases performed) to 98.1%
(137 cases performed). The operator who had the greatest
number of cases (325) had a success rate of 95.8%.
Complications occurred in 299 cases (6.4%). Of these,
270 (5.99%) were minor and 29 (0.62%) were major. The
minor complications consisted of 202 (3.32%) grade 1
hematomas and 39 (0.83%) grade 2 hematomas. The oxy-
gen saturation dropped below 90% during the procedure
in 10 cases (0.21%). Nine patients had delayed bleeding
as a complication, eight cases had an adverse reaction
to medication, and there were two cases of infection of
the graft that occurred during the 30 days following the
procedure. The 29 major complications consisted of 19 in-
stances (0.41%) of grade 3 hematoma, 18 cases (0.38%)
of peripheral artery embolism, and two patients who died
during the 30 days following the procedure on their graft,
one at 10 and one at 17 days.
The mean procedure time (Table 2) for all graft de-
clots was 51.8 ± 27.6 minutes. The median time was 45
minutes, with a range of 12 to 220 minutes. The median
for individual operator mean procedure times was 53.8 ±
5.6 minutes (212 cases performed), with a range of 36 ±
17.2 (325 cases performed) to 81.2 ± 32.5 minutes (36
cases performed). The mean fluoroscopy time was 8.8 ±
6.4 minutes, with a median of 6.9 minutes and a range
of 0.2 to 48.5 minutes. The median for individual opera-
tor mean fluoroscopy times was 9.3 ± 5.1 minutes (137
cases performed), with a range of 3.3 ± 1.6 (278 cases
performed) to 17.5 ± 6.2 minutes (28 cases performed).
DISCUSSION
It is of interest to note that the distribution of cases be-
tween angioplasty, thrombectomy, and catheter-related
procedures was about equal. This is a typical distribution
of cases for outpatient, freestanding facilities of the type
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represented in the study. The numerical difference be-
tween fistula-related and graft-related cases is partially
reflective of the access profile present in the populations
being served and partially due to the fact that fistulas have
fewer problems than grafts. The difference between the
ratios of angioplasties to thrombectomies for fistulas ver-
sus grafts is due to the fact that the thrombosis rate for
fistulas is much lower than that for grafts.
The NKF-K/DOQI guidelines define tunneled dialysis
catheter success as an ability to deliver at least 300 mL/
min blood flow during the first attempted dialysis [3].
Guideline 34 states that the primary failure rate for place-
ment should not exceed 5% [6]. In this study the com-
bined failure rate for 1765 primary catheter placements
was 1.76% (failed in 1.08% and aborted in 0.68%). For
the 2262 catheters placed as part of a catheter exchange
the combined failure rate was 1.64% (1.11% failed and
0.53% were aborted). This gave a combined success rate
for all 4027 catheters of 98.32% (Table 1). Although
there are small series of tunneled catheter placements
[7] that have reported 100% primary success rate, this
level of success is certainly superior to that prescribed by
NKF- K/DOQI.
A variety of complications can occur at the time of
tunneled catheter placement. The major determinant
for these problems is the experience of the operator
[8] and whether or not ultrasound guidance is used for
cannulation [9]. Even in the hands of an experienced
surgeon in the operating room, blind insertion can re-
sult in complication rates as high as 5.9% [10, 11]. These
complications [12] include pneumothorax (0% to 1.8%),
hemothorax (0% to 0.6%), hemomediastinum (0% to
1.2%), recurrent laryngeal nerve palsy (0% to 1.6%),
and bleeding that required exploration and/or transfu-
sion (0% to 4.7%). In a report of 237 catheters [13]
designed to demonstrate that an interventional radiol-
ogist could be as successful as a surgeon, a complication
rate of 4.22% was reported. Of these, 2.5% were due
to six cases of pneumothorax and two cases of air em-
bolism. The conclusion of this report was in favor of the
radiologists.
Most of the complications of catheter placement are
related to the cannulation of the vein, and these adverse
events can generally be avoided by using real-time ul-
trasound guidance [9]. The use of ultrasound is strongly
recommended by NKF-K/DOQI guideline 5 [14]. How-
ever, since the technology is readily available and the
complication rate without it is so significant, it should be
considered mandatory. All of the catheters placed in this
series were done with both ultrasound and fluoroscopic
guidance.
The 1.42% complication rate observed with primary
tunneled catheter placement seems to be quite accept-
able, especially in view of the fact that only one major
complication was seen (0.06%). The most frequently ob-
served problem was related to oozing at the cannulation
and exit sites. This incidence was significantly less than the
2% threshold recommended by NKF-K/DOQI guideline
34 [6]. All of the 29 complications observed with catheter
exchange were of the minor variety, which is what one
would expect to see with a procedure of this type.
In this series, 36.4% of the procedures performed in-
volved the prospective treatment of venous stenosis. Ap-
proximately one third (1561) of these were patients with
arteriovenous fistulas (Table 1). In these patients, the
technical success rate was 96.58%. There are only a few
small studies available that present data derived strictly
from fistulas. These have reported a success rate ranging
from 89.5% to 97% [15–19]. The largest of these involved
a series of 100 cases [19]. This report had a 97% success
rate, with a complication incidence of 6.6%. The AVF an-
gioplasties in the current series had a success rate compa-
rable to this study, but a complication rate (4.48%) that
surpasses it. Turmel-Rodrigues [20] has reported an 8%
incidence of vein rupture with radial-cephalic fistulas and
15% with upper arm fistulas. This rather high complica-
tion rate represents a considerable difference from what
was observed in the current larger series. The majority of
the complications observed in the fistula cases in the cur-
rent report were minor, with hematoma formation being
the most common occurrence. Only three major compli-
cations occurred, and these were all related to grade 3
hematomas.
Not all cases of venous stenosis associated with a dialy-
sis access graft can be successfully treated by angioplasty.
Failure, when it occurs, may be related to the presence of
a lesion that cannot be crossed with a guidewire, or it may
be related to a lesion that has a post-treatment residual
that exceeds the accepted definition for success [1]. The
success rates that have been reported in the literature for
this procedure are in the range of 82% to 98% [21–26].
The success of the cases reported here is equal to the
top end of that spectrum, with a success rate of 98.06%
(Table 1). The major complication associated with an-
gioplasty of hemodialysis grafts is vein rupture [5, 30].
The incidence of this complication has been reported to
be in the range of 1.7% to 3.8% [23, 27–30]. The 0.93%
combined rate (all grades) noted in this series is certainly
better than what has been previously reported. As with
AVF-PTA, the majority of the complications associated
with graft-PTA were of the minor variety, and the bulk of
these were related to grade 1 and grade 2 hematomas.
The two deaths that are listed as complications were
not temporally associated with the procedures, they
only occurred within the 30-day period required by the
definition.
The thrombosis rate for an AVF is reported to be
approximately one sixth that for synthetic grafts [31].
Nevertheless, with increasing numbers of fistulas in use
within a practice, clotted fistulas will present to the
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interventional facility. In the past, the prevailing dogma
suggested that a clotted AVF could not be successfully
treated [32]. The fallacy of this opinion has been demon-
strated by this and previous studies [33–39]. However,
when a fistula thromboses, the nature of the problem is
somewhat different than a clotted graft. The thrombec-
tomy procedure for a graft can be standardized to a great
degree. This is not the case with a fistula; it has to be indi-
vidualized. The degree of stenosis is generally much more
severe, its location is variable, and the presence of col-
laterals may make the anatomy very difficult to unravel
radiographically. Additionally, cannulation may be a
challenge. These difficulties are reflected by the longer
procedure and fluoroscopy times recorded with these
cases (Fig. 2). The thrombus volume in a thrombosed
fistula is quite variable, ranging from minimal to large
[34]. In most cases, it is minimal, with much of the fistula
remaining patent because of the development of collater-
als. For all of these reasons, the exact technique required
may vary considerably, and there is a steep learning curve
when it comes to performing thrombectomies on arteri-
ovenous fistulas [33]. This was manifest by considerable
variability in results between individual physician opera-
tors in performing this procedure. With very small num-
bers of cases, a single failure results in a major percentage
shift.
With only 228 cases of fistula thrombectomy and half of
the 29 operators performing eight or fewer cases, it has
been difficult to gain significant experience in this pro-
cedure. Nevertheless, the success rate obtained of 78%
is comparable to that which has been reported in the
literature, which ranges from 73% to 100% [33–39]. In
one series of 73 upper extremity fistulas [35], the inci-
dence of major complications was 9.5%. These included
a pulmonary embolus, a bleeding episode that required
transfusion, and five instances (6.5%) of vein rupture that
required stent placement. This latter complication would
be comparable to our grade 3 hematoma. Compared to
this report, the complication rate observed in this series
with a minor complication rate of 7.45% and a single
major complication (0.44%) looks very good. The major
complication was a grade 3 hematoma. Most of the minor
complications (5.7%) were grade 1 hematomas with no
significant clinical sequela.
An inescapable relationship exists between the use
of a polytetrafluoroethylene (PTFE) graft as a dialy-
sis access and thrombosis. Endovascular thrombectomy
has become a common approach for its management.
There are a variety of techniques that have been used for
this purpose, including balloon-assisted thrombectomy,
pulse-spray pharmacomechanical thrombolysis, and a
variety of different thrombectomy devices. Although
some differences in success have been reported, no
clear advantage of one technique over another has ever
been documented. Reported success rates for endovas-
cular thrombectomy have ranged from 62% to 95%
[40–56].
Most series of endovascular thrombectomy that have
been reported have been relatively small; very few have
exceeded 100 cases. Considerable variability exists in
these patients. There is variability in location of the graft,
age of the graft, degree of stenosis, location of stenosis,
and number of prior procedures that may have been per-
formed. For these reasons a small series must raise ques-
tions concerning significance. The largest series (1176
cases) that has been reported had a success rate of 95%
[46]. The 93% success rate documented in this series of
4671 cases compares well with reports in the literature
and significantly exceeds the minimum success rate of
85% prescribed by NKF-K/DOQI Guideline 21 [57].
The combined minor and major complication rate as-
sociated with this category of procedure (multiple tech-
niques) has been reported to be as high as 10% to 16%
[58, 59]. The 6.4% incidence noted in this series is well
below this range. The most complete presentation of the
complications associated with endovascular thrombec-
tomy from a single institution available is a report based
upon a retrospective review of 935 cases [60]. In this pa-
per, an overall complication rate of 3.3% was observed.
Major complications made up 2% of these, and 1.3% were
minor. While the overall incidence of procedure-related
adverse events is better than that seen in this current
series with 6.4% complications, the incidence of major
complications (0.66%) is considerably lower. The most
common complication reported in association with the
endovascular thrombectomy procedure is vein rupture,
resulting in what we have referred to as a grade 1, and, to
a lesser degree, a grade 2 hematoma [46, 60]. This was also
the case here with 5.15% of the observed complications
falling within this category. The major unique procedure-
related complication requiring interventional therapy is
the occurrence of a peripheral artery embolus [5]. The
incidence of this problem has been reported to be as high
as 6% in some studies [53]; however, the frequency with
which arterial emboli are reported is strongly influenced
by the diligence with which they are sought. In most series
the reported incidence actually reflects the incidence of
symptomatic occurrence. In the current series an arterial
embolus was diagnosed in 0.38% of the cases; the percent-
age of these that were symptomatic was not recorded.
Table 3 compares the complications that have been re-
ported in the literature [40–57] with those seen in this
study.
The timed components of the procedures (Table 2) are
of importance. The duration of the procedure time re-
lates to two factors: the skill of the operator and the dif-
ficulty of the case. In most instances, the operators with
the longest mean procedure times were the ones with
the least number of cases. However, even those opera-
tors with the greatest experience had an occasional long
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Table 3. Comparison of complication rates reported in literature
[40–57] for graft thrombectomy compared to current series
Complication Literature Current series
Venous rupture/hematoma 1.2–7% 5.57%
4.32%–Gr 1
0.83%–Gr 2
0.41%–Gr 3
Arterial emboli 1.2–6.7% 0.38%
O2 sat <90% Not reported 0.21%
Acute respiratory arrest 1.6–2.3% None
Minor bleeding 2.8–11.1% 0.19%
Major bleeding 0.7–1.7% None
Medication reaction 0.7–1.4% 0.17%
Sepsis/infection 1.2–2.0% 0.04%
Death 0–1.5% 0.04%
case. It is important that an operator be able to perform
these cases in a timely manner for several reasons. First,
the patients are sedated using a short-acting sedative, and
if the case is too long, repetitive administration of seda-
tive is required. This adds to the patient’s discomfort and
can increase the complications related to the drugs be-
ing used. Second, many of the patients require dialysis.
Getting the procedure completed and the patient to the
dialysis clinic is a high priority. Third, interventional fa-
cilities of the type involved in this study support dialysis
patient populations of such size that six to eight cases per
day are usual, and occasionally, as many as 12 to 13 cases
may present requiring treatment.
The mean time for all of the procedures combined was
39.5 minutes (Table 3). Half of the procedures were com-
pleted in 33 minutes (median time) or less. Account-
ing for patient and procedure room preparation, this
generally allows for one patient to be cared for each
hour. The thrombectomy procedures required the most
time, especially when a fistula was involved. These proce-
dures are definitively more involved and more difficult to
accomplish.
The fluoroscopy times are also quite important as an
index of radiation safety both for the patient and for per-
sonnel. It is important that these times be kept as short as
can be reasonably achieved. A mean time of 5.9 minutes
was recorded for the total group of procedures, with half
being accomplished in 4.2 minutes (median time) or less.
Most of the hemodialysis vascular access procedure se-
ries that have been reported do not list either procedure
or fluoroscopy times so comparison is difficult. However,
there are a number of reports of endovascular thrombec-
tomy series on grafts in which procedure times are listed.
These relate to thrombectomies done by a variety of per-
cutaneous techniques. The procedure times given in these
various reports range from 33 minutes up to 3.5 hours [43,
46, 61–64]. The mean time of 51.8 minutes for the 4671
graft thrombectomies reported here falls within the lower
portion of this range. It should be noted that half of the
procedures were performed in 45 minutes (median time)
or less.
CONCLUSION
Considerable concern has been expressed relative to
training requirements for physicians performing inter-
ventional procedures on hemodialysis vascular access
[65–67]. While this is understandable, the effectiveness
and safety with which these procedures are performed
is ultimately what is important, and it is this that should
be given major consideration. Intuitively, one would con-
clude that there is a learning curve for procedures of the
type described here, but it is of interest that in only one
instance did the operator with the greatest experience as
far as case numbers are concerned have the best result
of the series. When the overall results obtained in the
cases represented in this series, performed by a diverse
group of interventional nephrologists, are compared with
that which have been reported in the medical literature
derived primarily from interventional radiologists, it is
clear that interventional nephrologists can perform these
procedures both effectively and safely. An overall suc-
cess rate of 94.86% for 14,067 procedures with a ma-
jor complication rate of only 0.28%, a procedure time
of 39.5 minutes, and a fluoroscopy time of 5.9 minutes is
unsurpassed.
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